The study was funded by the National Institute of Mental Health.
The study was conducted at Ohio State University.
The study received funding from the University of Ottawa and the Canada Research Chairs Program (MTW).
A team of researchers constructed a biophysically realistic whole-brain model to further understand the effects of psilocybin in the brain.
The findings were presented at the 58th Annual Meeting of The American College of Neuropsychopharmacology.
Psychedelic microdosing could be more beneficial for improving mood and attention than previously thought, according to a new preliminary study. “About 9 years ago, I heard about microdosing, and followed up since
The research was presented recently at the American Psychological Association’s annual meeting.
The evidence is mounting that psychedelics hold promise in enhancing our current understandings of mental health problems.
Psilocybin can be beneficial in treatment-resistant depression, study finds.